GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Cerubidine® | daunomycin | FI-6339 | NDC-0082-4155 | RP-13057
                                 daunorubicin is an approved drug (FDA (1979), EMA (2018)) Compound class: 
                                                            Natural product
                                 
                                    
                                        Comment: Daunorubicin is an anthracycline class chemotherapeutic for cancer treatment. It has also been shown to potentiate the activity of antibacterial agents of last resort, against multi-drug resistant (MDR) Gram-negative bacteria [1]. Daunorubicin is on the World Health Organisation's List of Essential Medicines. | 
 | |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target. |